Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee: SGLT-2 Inhibitors and Diabetic Ketoacidosis

Title Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee: SGLT-2 Inhibitors and Diabetic Ketoacidosis
Date
Thursday, January 17, 2019
Link
Related Links
Medical Product
canagliflozin
dapagliflozin
empagliflozin
sitagliptin
sodium-glucose cotransporter-2 (SGLT-2) inhibitor
Health Outcome
diabetic ketoacidosis